Answer: C (AngleMRN and AngleNRO)
Step-by-step explanation:
A linear pair of angles is formed when two lines intersect. Two angles are linear if they are adjacent angles (angles next to each other) formed by two intersecting lines. The measure of a straight angle is 180 degrees, so a linear pair of angles must add up to 180 degrees.
AngleMRN and AngleNRO together is 180 degrees
I'm not very good at explaining but hope this helps ! :)
10 is your answer because it is a terminating or repeating decimals
Answer:
3.590.04
Step-by-step explanation:
The formula given for total amount saved when compounding interest =
A = P(1 + r/n)^nt
Where
A = Total amount saved after t years
P = Principal or initial amount saved
r = Interest rate
n = compounding frequency
t = time in years
From the above question
P = 3000
r =6% = 0.06
n =compounded monthly = 12
t = 3 years
Hence,
A = 3000(1 + 0.06/12)^3 × 12
A = 3000(1 + 0.06/12)^36
A = 3,590.04
Therefore, the total amount Imran will have in his account after 3 years = 3,590.04
Answer:
A diagonal. (A rectangle is divided into two triangles by a diagonal, for example.)
Answer:
H0: The new cancer drug increases the mean survival time by 30 days
Ha: The new cancer drug increases the mean survival time by 30 or more than 30 days.
If fail to reject H0 (the null hypothesis), the conclusion is that the new cancer drug increases the mean survival time by 30 days.
Step-by-step explanation:
The null hypothesis is a statement from a population parameter which is either rejected or accepted (fail to reject) upon testing. It is expressed using the equality sign.
The alternate hypothesis is also a statement from a population parameter which negates the null hypothesis and is accepted if the null hypothesis is rejected. It is expressed using any of the inequality signs.
The test is a two-tailed test because the alternate hypothesis is expressed using more than or equal to.
If I fail to reject H0, it means the test statistic falls within the region bounded by the critical values.
It would therefore be concluded that the new cancer drug increases the mean survival time by 30 days.
